SOAN
AngioSoma, Inc. [SOAN] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SOAN Stock Summary
In the News
SOAN Financial details
Company Rating
-
Market Cap
0
Income
-5.54M
Revenue
0.08
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-37.6
Forward P/E
-
PEG
3.3867069197826E+16
P/S
-
P/B
-30.9
P/C
-
P/FCF
-
Quick Ratio
0.11
Current Ratio
0.12
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.01
EPS next Y
-
EPS next Q
-
EPS this Y
-84.87%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
405.26%
-
-
-
-
SMA20
-
SMA50
-50%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-603%
ROE
81%
ROC
0.46%
Gross Margin
-48838%
Oper. Margin
-394378%
Profit Margin
-703547%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.06-0.074
52W High
-
52W Low
-
RSI
46.34
Rel Volume
0.43
Avg Volume
4.42M
Volume
1.9M
Perf Week
-17.92%
Perf Month
-32.56%
Perf Quarter
-
Perf Half Y
64.15%
-
-
-
-
Beta
-0.283039
-
-
Volatility
0%, 0%
Prev Close
-6.95%
Price
0.0087
Change
6.1%
Company Profile
- Volume Average 4.42M
- CEO Ms. Alex K. Blankenship
- Headquarters Houston,TX,US
- IPO Date 2022-01-31
-
Website
http://angiosoma.com 
AngioSoma, Inc., a wellness company, engages in the development and commercialization of dietary supplements to the medical, wellness, and adult-use markets. The company was founded in 2016 and is based in Houston, Texas.
